MDxHealth, EHC Innovation Collaborate
News Sep 29, 2016
MDxHealth SA has announced that it has signed a distribution agreement with The European Health Centre Innovation (EHC Innovation) to offer its SelectMDx(TM) for Prostate Cancer and ConfirmMDx® for Prostate Cancer tests to their urology customers throughout Poland.
Under the terms of the agreement, EHC Innovation will be one of two exclusive distributors of SelectMDx in Poland and the only exclusive distributor of ConfirmMDx. Samples will be sent to MDxHealth's clinical diagnostic laboratory in Nijmegen, The Netherlands for analysis. EHC Innovation will reimburse MDxHealth for all testing services.
"We are delighted to announce our collaboration with The European Health Centre Innovation which, as part of European Health Center Otwock Hospital, is the most technologically advanced multispecialty diagnostic centre in Poland. We believe that SelectMDx and ConfirmMDx perfectly complement EHC Innovation's existing portfolio of advanced diagnostic tools," commented Dr. Jan Groen, CEO of MDxHealth.
"With a strong reputation throughout the region and focus on improving patient care and outcomes, EHC Innovation is an ideal partner to help us raise awareness and expand access to SelectMDx and ConfirmMDx within the urology community."
Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.READ MORE